These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 9605053

  • 1. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.
    Janousek J, Paul T.
    Am J Cardiol; 1998 May 01; 81(9):1121-4. PubMed ID: 9605053
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A, Kramer HH, Krogmann ON, Rammos S, Bourgeous M.
    Eur Heart J; 1994 Aug 01; 15(8):1050-6. PubMed ID: 7527342
    [Abstract] [Full Text] [Related]

  • 3. Guidelines for the use of propafenone in treating supraventricular arrhythmias.
    Kishore AG, Camm AJ.
    Drugs; 1995 Aug 01; 50(2):250-62. PubMed ID: 8521758
    [Abstract] [Full Text] [Related]

  • 4. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G.
    Monatsschr Kinderheilkd; 1985 Mar 01; 133(3):154-7. PubMed ID: 4010670
    [Abstract] [Full Text] [Related]

  • 5. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 6. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias.
    Reimer A, Paul T, Kallfelz HC.
    Am J Cardiol; 1991 Sep 15; 68(8):741-4. PubMed ID: 1892080
    [Abstract] [Full Text] [Related]

  • 8. Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up.
    Guccione P, Drago F, Di Donato RM, Cicini MP, Pasquini L, Marino B, Marcelletti C, Ragonese P.
    Am Heart J; 1991 Oct 15; 122(4 Pt 1):1022-7. PubMed ID: 1927853
    [Abstract] [Full Text] [Related]

  • 9. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct 15; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 10. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ, Anderson JL.
    Am J Cardiol; 1996 Aug 15; 78(4):430-4. PubMed ID: 8752188
    [Abstract] [Full Text] [Related]

  • 11. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.
    Fish FA, Gillette PC, Benson DW.
    J Am Coll Cardiol; 1991 Aug 15; 18(2):356-65. PubMed ID: 1906902
    [Abstract] [Full Text] [Related]

  • 12. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M, Cullen MT, Casadei G.
    Eur Heart J; 1995 Dec 15; 16(12):1943-51. PubMed ID: 8682031
    [Abstract] [Full Text] [Related]

  • 13. Propafenone: an effective agent for the management of supraventricular arrhythmias.
    Grant AO.
    J Cardiovasc Electrophysiol; 1996 Apr 15; 7(4):353-64. PubMed ID: 8777484
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X, Zhang Y, Liu H, Jiang H, Ge H, Zhang Y.
    Am J Cardiol; 2017 May 01; 119(9):1366-1370. PubMed ID: 28283175
    [Abstract] [Full Text] [Related]

  • 15. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP.
    Am J Cardiol; 1998 Oct 16; 82(8A):59N-65N. PubMed ID: 9809902
    [Abstract] [Full Text] [Related]

  • 16. Encainide for resistant supraventricular tachycardia in children: follow-up report.
    Strasburger JF, Smith RT, Moak JP, Gothing C, Garson A.
    Am J Cardiol; 1988 Dec 20; 62(19):50L-54L. PubMed ID: 3144168
    [Abstract] [Full Text] [Related]

  • 17. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 20; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 18. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM, Palmer KJ, Langtry HD, Fitton A.
    Drugs; 1993 Jan 20; 45(1):85-130. PubMed ID: 7680987
    [Abstract] [Full Text] [Related]

  • 19. [Propafenon therapy of arrhythmias in infancy and childhood (author's transl)].
    Weber H, Eigster G, Wesselhoeft H.
    Monatsschr Kinderheilkd; 1981 Jul 20; 129(7):410-3. PubMed ID: 6167855
    [Abstract] [Full Text] [Related]

  • 20. Complex dysrhythmias in infants and children.
    Hanisch DG, Perron L.
    AACN Clin Issues Crit Care Nurs; 1992 Feb 20; 3(1):255-69. PubMed ID: 1554568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.